(S)-Methocarbamol
CAS : 108914-10-9
Ref. 3D-IEA91410
| 1mg | Arrêté | ||
| 2mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté |
Informations sur le produit
- 1,2-Propanediol, 3-(2-methoxyphenoxy)-, 1-carbamate, (2S)- (9CI)
- 1,2-Propanediol, 3-(2-methoxyphenoxy)-, 1-carbamate, (S)-
(S)-Methocarbamol is a medicinal compound that has shown potential as an anticancer agent. It is an analog of Chinese herbal medicine and has been found to inhibit the activity of kinases, which are enzymes involved in cell signaling pathways. This inhibition can lead to apoptosis (programmed cell death) in cancer cells, making it a promising inhibitor for tumor growth. (S)-Methocarbamol has been shown to be effective against human cancer cell lines and has potential as a therapeutic agent for cancer treatment. Its ability to inhibit protein kinases could make it a valuable tool in developing novel cancer therapies. Additionally, (S)-Methocarbamol has been found to be excreted primarily through urine, indicating that it may have low toxicity levels and could be a safe option for cancer treatment.
